Understand regulatory language in clinic information

Begin with the exact claim

Write down the clinic’s wording and ask for the named product, manufacturer, intended use, and official record. Regulatory terms apply to particular objects and processes. A useful record has enough detail for you and your clinician to check the same claim later.

This is a guide to reading public information, not a legal determination about a clinic or product. If the record and explanation do not align, ask the relevant authority or a qualified professional to clarify the discrepancy before relying on the claim.

FDA approval

FDA approval concerns a specified product and its intended use. FDA’s overview explains that approval of a drug reflects the agency’s assessment of benefits and risks for the approved use. It does not mean that a product is free of risk, or that every use of the product has been evaluated.

Ask: “Which product is approved, and where does its approved labeling describe the use you propose?” For cellular and gene therapies, start with FDA’s current approved-products list and follow the product-specific documentation. Do not infer current approval status solely from an older general consumer article.

Device clearance and other device pathways

Devices have different marketing pathways. FDA describes 510(k) clearance, premarket approval, De Novo classification, and exemptions among them. A 510(k) decision concerns substantial equivalence to a legally marketed predicate device; it is not the same regulatory decision as premarket approval.

Ask for the device name, record number, and intended-use documentation. A reference to a cleared preparation device does not, on its own, establish that every clinical application of material prepared with it has FDA approval. Match the claim to the scope of the actual record.

Establishment registration and product listing

Registration and listing are distinct from approval. FDA states that registration of an establishment or listing of a drug or device does not denote approval. FDA also does not approve health care providers such as physician offices. A displayed registration number cannot answer whether a proposed intervention is effective for your condition.

Label each record accurately in your notes: facility registration, product listing, device decision, or professional license. Ask what additional documentation supports the clinical claim being made.

Investigational status and trial registration

A research listing is information about a study. FDA warns that appearing in ClinicalTrials.gov does not establish that a regenerative medicine product is legally marketed. Ask for the study identifier, sponsor, investigator, site, consent materials, and an explanation of the regulatory and ethics oversight that applies.

Ask whether the clinic is an actual participating site and whether the proposed visit is research participation or ordinary paid care. A study title or registration number should lead to those practical answers. Research oversight and a study’s existence are not evidence that its intervention has already demonstrated benefit.

Off-label use and expanded access

FDA’s patient explanation of off-label drug use concerns an approved drug used in a way not included in its approved labeling, such as a different condition, dose, or route. FDA has not determined safety and effectiveness for that unapproved use. The term does not automatically describe an unidentified or unapproved product.

Expanded access is a separate potential pathway to an investigational product outside a clinical trial for certain serious or immediately life-threatening conditions when satisfactory alternatives are unavailable. Eligibility and authorization need specific assessment; the phrase is not a general marketing permission.

Keep a record you can verify

For each claim, retain the date, exact wording, product or device name, official link, and the clinician’s explanation of how it applies. Put unresolved questions alongside the record. Licensing, board certification, FDA product regulation, research oversight, and clinical evidence are separate checks; a positive answer to one does not supply the others.

Questions to bring

• What exactly does this regulatory statement apply to?
• Can you show me the official record and the intended use?
• Is the proposed care research, an approved use, or another use requiring explanation?

Sources and editorial context

This reference was compiled from the sources below and has not received independent clinical review. Use it to understand terms and prepare questions for a qualified professional who can consider your circumstances.